Search results for " Neutral"
showing 10 items of 654 documents
"Figure 8-4" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4, 20-60\%$ centrality
"Figure 9-3" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4/v_2^2, 40-60\%$ centrality
"Figure 21" of "Neutral pion production with respect to centrality and reaction plane in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
Centrality dependence of $p_T$ ingetrated $R_{AA}(\Delta \phi)$
"Figure 8-2" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4, 20-40\%$ centrality
"Figure 9-2" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4/v_2^2, 20-40\%$ centrality
"Figure 9-1" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4/v_2^2, 0-20\%$ centrality
"Figure 9-4" of "Azimuthal anisotropy of pi^0 and eta mesons in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ meson $v_4/v_2^2, 20-60\%$ centrality
"Figure 11" of "Neutral pion production with respect to centrality and reaction plane in Au+Au collisions at sqrt(s_NN)=200 GeV"
2020
$\pi^0$ nuclear modification factors
"Table 44: figure 6b" of "Production of $\pi^0$ and $\eta$ mesons in Cu$+$Au collisions at $\sqrt{s_{_{NN}}}$=200 GeV"
2021
$\pi^0$ $R_{AB}$ supplemental to figure 6b from 40-50% semi-central Au+Au collisions. Type A uncertainties are uncorrelated point-to-point. Type B uncertainties are correlated point-to-point. Type C uncertainties affect the scale of the data.
An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults
2012
Please cite this paper as: Gillard et al. (2012) An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750‐2659.2012.00349.x. Background Long‐term persistence of immune response and safety of an H5N1 prepandemic influenza vaccine adjuvanted with AS03 (an α‐tocopherol oil‐in‐water emulsion‐based adjuvant system) was evaluated using various prime‐boost schedules that mimicked potential pandemic scenarios (NCT00430521). Methods Five hundred and twelve healthy adults aged 18–60 years received primary vaccination with one or two doses (0, 21 days schedule…